MIRACLE₂ Score Compared With Downtime and Current Selection Criterion for Invasive Cardiovascular Therapies After...

Area of Science:

• Cardiology
• Emergency Medicine
• Clinical Research

Background:

• The MIRACLE2 score is a unique risk assessment tool for guiding post-out-of-hospital cardiac arrest (OHCA) therapy selection.
• Existing risk scores often incorporate factors that may limit their utility in specific OHCA patient groups.

Purpose of the Study:

• To compare the predictive performance of the MIRACLE2 score against downtime and current randomized controlled trial (RCT) recruitment criteria.
• To assess the ability of these metrics to predict poor neurologic outcomes in OHCA survivors.

Main Methods:

• Retrospective analysis of 1,259 patients from the EUCAR registry (May 2012-September 2022).
• Primary outcome: poor neurologic outcome (Cerebral Performance Category 3-5) at hospital discharge.
• Multivariable logistic regression and area under the curve (AUC) analysis were used to compare prediction models.

Main Results:

• MIRACLE2 score demonstrated superior discrimination for poor neurologic outcome (AUC: 0.877) compared to total downtime (AUC: 0.732), low flow (AUC: 0.725), and zero flow (AUC: 0.610).
• The MIRACLE2 score showed a stronger association with poor outcome (OR: 2.23) than downtime metrics.
• Positive predictive value of MIRACLE2 (≥5) for poor outcome (0.92) was significantly higher than established RCT exclusion criteria.

Conclusions:

• The MIRACLE2 score offers superior prediction of outcomes post-OHCA compared to simple downtime.
• It exhibits higher discrimination of poor neurologic outcomes than current RCT recruitment criteria.
• Future RCTs should formally investigate the MIRACLE2 score's potential to enhance patient selection for OHCA treatment.